Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00163163
Status:
COMPLETED
Last Update Posted:
2021-02-18
First Post:
2005-09-09
Brief Title:
Carotid Atorvastatin Study in Hyperlipidemic Post-Menopausal Women
Sponsor:
Pfizers Upjohn has merged with Mylan to form Viatris Inc
Organization:
Pfizer
Study Overview
Official Title:
Carotid Atorvastatin Study In Hyperlipidemic Post-Menopausal Women A Randomized Evaluation of Atorvastatin Versus Placebo CASHMERE
Status:
COMPLETED
Status Verified Date:
2021-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the effect of atorvastatin 80 mg versus placebo given for 12 months on carotid intima-media thickness in postmenopausal women with moderate hypercholesterolemia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None